![]() ![]() Favipiravir versus arbidol for COVID-19: a randomized clinical trial. 2020.Ĭhen C, Zhang Y, Huang J, Cheng Z, Wu J, Chen S et al. Favipiravir: Pharmacokinetics and concerns about clinical trials for 2019-nCoV infection. China approves first anti-viral drug against coronavirus Covid-19. Ini Alasan PDPI Rekomendasikan Tamiflu Sebagai Obat Covid-19 di Indonesia. Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Tan EL, Ooi EE, Lin CY, Tan HC, Ling AE, Lim B, et al. Drug treatment options for the 2019-new coronavirus (2019-nCoV). ![]() Gilead Announces Approval of Veklury® (remdesivir) in Japan for Patients With Severe COVID-19. Assessment of Evidence for COVID-19-Related Treatments: Updated. ![]() Perhimpunan Dokter Paru Indonesia (PDPI), Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI), Perhimpunan Dokter Anestesiologi dan Terapi Intensif Indonesia (PERDATIN), Ikatan Dokter Anak Indonesia (IDAI). Treatment of Coronavirus Disease 2019 (COVID-19): Investigational Drugs and Other Therapies. Rolling updates on coronavirus disease (COVID-19). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |